keyword
https://read.qxmd.com/read/38621326/addressing-positive-multi-cancer-early-detection-tests-in-head-and-neck-surgery-experience-with-head-and-neck-work-up-for-high-risk-referrals
#1
JOURNAL ARTICLE
Forrest W Fearington, Conan Y Zhao, Santiago Romero-Brufau, Eric J Moore, Daniel L Price, Kendall K Tasche, Linda X Yin, Elizabeth T Kunkel, John B Kisiel, Karthik V Giridhar, David M Routman, Kathryn M Van Abel
OBJECTIVES: Blood-based multi-cancer early detection (MCED) tests are now commercially available. However, there are currently no consensus guidelines available for head and neck cancer (HNC) providers to direct work up or surveillance for patients with a positive MCED test. We seek to describe cases of patients with positive MCED tests suggesting HNC and provide insights for their evaluation. METHODS: Retrospective chart review of patients referred to Otolaryngology with an MCED result suggesting HNC...
April 14, 2024: Oral Oncology
https://read.qxmd.com/read/38621307/primary-intracranial-peripheral-primitive-neuroectodermal-tumor-lessons-from-an-exceptionally-rare-neoplasm-illustrative-case
#2
JOURNAL ARTICLE
Jhon E Bocanegra-Becerra, Luis Felipe Novoa-Ramírez, Alan Jesús Latorre-Zúñiga, Norka Tacas-Gil, Rolando Rojas-Apaza
BACKGROUND: The primary intracranial peripheral primitive neuroectodermal tumor (pPNET) is a lesion subtype within the Ewing sarcoma family of tumors. pPNETs are extremely uncommon pathologies, accounting for 0.03% of intracranial tumors and 1% to 2% of Ewing sarcoma cases. Given its histological aspect similar to other highly proliferative malignant neuroectodermal neoplasms, pPNET merits extensive workup for accurate diagnosis and treatment. OBSERVATIONS: A 36-year-old male presented to the emergency department with a 1-year history of headaches in the right frontoparietal area, generalized tonic-clonic seizures, and a history of the resection of a tumor labeled as a meningioma 5 years before admission...
April 15, 2024: J Neurosurg Case Lessons
https://read.qxmd.com/read/38619599/familial-syndromes-associated-with-testicular-and-paratesticular-neoplasms-a-comprehensive-review
#3
REVIEW
Andrea Strakova-Peterikova, Maryna Slisarenko, Josef Skopal, Kristyna Pivovarcikova, Tomas Pitra, Mihaela Farcas, Michael Michal, Michal Michal, Kvetoslava Michalova
A syndromic association between a subset of testicular/paratesticular neoplasms is well established. Such examples include Carney complex and large cell calcifying Sertoli cell tumor, Peutz-Jeghers syndrome and intratubular large cell hyalinizing Sertoli cell neoplasia, and VHL syndrome and clear cell papillary cystadenoma of the epididymis.However, recent studies proposed potential novel links between some testicular and paratesticular neoplasms with certain tumor syndromes. While more studies are still needed to solidify these associations, recent research suggests that a subset of Leydig cell tumors may arise in patients with hereditary leiomyomatosis and renal cell carcinoma syndrome or that some seminomas may occur in Lynch syndrome patients...
April 15, 2024: Virchows Archiv: An International Journal of Pathology
https://read.qxmd.com/read/38576799/metastatic-clear-cell-sarcoma-of-the-pancreas-a-rare-case-report
#4
Yu-Jing Liu, Chen Zou, Yong-You Wu
BACKGROUND: Clear cell sarcoma (CCS) is a rare soft-tissue sarcoma. The most common metastatic sites for CCS are the lungs, bones and brain. CCS is highly invasive and mainly metastasizes to the lung, followed by the bone and brain; however, pancreatic metastasis is relatively rare. CASE SUMMARY: We report on a rare case of CCS with pancreatic metastasis in a 47-year-old man. The patient had a relevant medical history 3 years ago, with abdominal pain as the main clinical manifestation...
March 16, 2024: World Journal of Clinical Cases
https://read.qxmd.com/read/38556256/fusion-driven-cutaneous-and-superficial-mesenchymal-and-adnexal-tumors-a-clinicopathologic-and-molecular-study-of-15-cases-including-a-novel-case-of-actb-zmiz2-rearranged-adnexal-carcinoma
#5
JOURNAL ARTICLE
Carina A Dehner, Emma F Johnson, Carrie N Wieland, Michael J Camilleri, Andre Kajdacsy-Balla, Andre M Oliveira, Kevin C Halling, Sounak Gupta, Ruifeng Guo
BACKGROUND: While the list of fusion-driven soft tissue neoplasms is expanding rapidly, their importance among cutaneous and superficial mesenchymal and adnexal neoplasms remains poorly understood. This challenge is especially evident in cases with ambiguous histopathology that are difficult to classify based on morphology. AIMS: Our goal was to investigate the benefits of next-generation sequencing in diagnosing complex cutaneous neoplasms. MATERIALS & METHODS: Departmental archives were searched for fusion-driven cutaneous neoplasms...
March 31, 2024: Journal of Cutaneous Pathology
https://read.qxmd.com/read/38554313/endometrial-stromal-tumors-a-clinico-histomorphological-spectrum-of-endometrial-stromal-tumors-with-review-of-literature
#6
REVIEW
Ankita Verma, Reena Tomar, Anubhuti Chaturvedi, Nimisha Dhankar, Varuna Mallya, Nita Khurana
BACKGROUND: Endometrial stromal tumors (ESTs) are rare subset of mesenchymal uterine neoplasms. There are heterogeneous morphological, immunohistochemical, and genetic features. Approximately 50% of ESTs occur in perimenopausal women. In 2020, WHO sub-categorized ESTs into four groups: endometrial stromal nodule (ESN), low-grade endometrial stromal sarcoma (LGESS), high-grade endometrial stromal sarcoma (HGESS), and undifferentiated uterine sarcoma (UUS). OBJECTIVE: To review the morphological spectrum of endometrial stromal tumors...
January 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38549939/exploration-of-the-molecular-biological-mechanisms-and-review-of-postoperative-radiotherapy-cases-in-tenosynovial-giant-cell-tumors
#7
JOURNAL ARTICLE
Tianwei Zhang, Bin Zeng, Ke Liu, Qin Zeng, Na Wang, Ling Peng, Hongbo Qiu, Xiaomei Chen, Lin Wang
Tendon Sheath Giant Cell Tumor (TGCT) is a benign tumor that primarily grows within joints and bursae. However, it has a high postoperative recurrence rate, ranging from 15% to 45%. Although radiotherapy may reduce this recurrence rate, its applicability as a standard treatment is still controversial. Furthermore, the pathogenic mechanisms of TGCT are not clear, which limits the development of effective treatment methods. The unpredictable growth and high recurrence rate of TGCT adds to the challenges of disease management...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38532886/the-rna-binding-proteins-larp4a-and-larp4b-promote-sarcoma-and-carcinoma-growth-and-metastasis
#8
JOURNAL ARTICLE
Jennifer C Coleman, Luke Tattersall, Val Yianni, Laura Knight, Hongqiang Yu, Sadie R Hallett, Philip Johnson, Ana J Caetano, Charlie Cosstick, Anne J Ridley, Alison Gartland, Maria R Conte, Agamemnon E Grigoriadis
RNA-binding proteins (RBPs) are emerging as important regulators of cancer pathogenesis. We reveal that the RBPs LARP4A and LARP4B are differentially overexpressed in osteosarcoma and osteosarcoma lung metastases, as well as in prostate cancer. Depletion of LARP4A and LARP4B reduced tumor growth and metastatic spread in xenografts, as well as inhibiting cell proliferation, motility, and migration. Transcriptomic profiling and high-content multiparametric analyses unveiled a central role for LARP4B, but not LARP4A, in regulating cell cycle progression in osteosarcoma and prostate cancer cells, potentially through modulating key cell cycle proteins such as Cyclins B1 and E2, Aurora B, and E2F1...
April 19, 2024: IScience
https://read.qxmd.com/read/38526767/a-comparison-of-clear-cell-sarcoma-to-jaw-and-salivary-tumors-bearing-ews-fusions
#9
REVIEW
Ornela Xhori, Navkiran Deol, Camron M Rivera, Jason Zavras, Sophia G Weil, Hirad Zafari, Julia C Thierauf, William C Faquin, Edwin Choy, Miguel N Rivera, A John Iafrate, Alexandre Jaquinet, Maria J Troulis
OBJECTIVE: To review tumors identified as "clear cell sarcoma" in order to determine similarities to the rare EWS fusion positive jaw and salivary gland tumors clear cell odontogenic carcinoma (CCOC) and clear cell carcinoma of the salivary gland (CCC). METHODS: PubMed was used to collect all reports of clear cell sarcoma (CCS). Search parameters were "clear cell sarcoma" and "CCS." References in the publications were screened and cross-referenced. Data extracted included demographic characteristics, presenting signs and symptoms, radiographic findings, histological and immunohistochemical features and known molecular/genetic aberrations...
March 25, 2024: Head and Neck Pathology
https://read.qxmd.com/read/38521373/back-to-the-future-selected-bone-and-soft-tissue-neoplasms-with-shared-genetic-alterations-but-differing-morphological-and-immunohistochemical-phenotypes
#10
REVIEW
Nooshin K Dashti, Casey P Schukow, Scott E Kilpatrick
Bone and soft tissue tumors (BST) are a highly heterogeneous group largely classified by their line of differentiation, based on their resemblance to their normal counterpart in adult tissue. Yet, rendering a specific diagnosis can be challenging, primarily due to their rarity and overlapping histopathologic features or clinical presentations. Over the past few decades, seemingly histogenetic-specific gene fusions/translocations and amplifications have been discovered, aiding in a more nuanced classification, leading to well-established objective diagnostic criteria and the development of specific surrogate ancillary tests targeting these genetic aberrations (e...
March 21, 2024: Human Pathology
https://read.qxmd.com/read/38501690/molecularly-defined-thoracic-neoplasms
#11
JOURNAL ARTICLE
Anja C Roden
Molecularly defined neoplasms are increasingly recognized, given the broader application and performance of molecular studies. These studies allow us to better characterize these neoplasms and learn about their pathogenesis. In the thorax, molecularly defined neoplasms include tumors such as NUT carcinoma, SMARCA4-deficient undifferentiated tumor (DUT), primary pulmonary myxoid sarcoma with EWSR1::CREB1 fusion, hyalinizing clear cell carcinoma, and SMARCB1-deficient neoplasms. Overall, these tumors are rare but are now more often recognized given more widely available immunostains such as NUT (NUT carcinoma), BRG1 (SMARCA4-DUT), and INI-1 (SMARCB1-deficient neoplasm)...
March 19, 2024: Advances in Anatomic Pathology
https://read.qxmd.com/read/38460673/intra-abdominal-epithelioid-neoplasm-with-ewsr1-creb-fusions-involving-the-kidney-a-clinicopathologic-and-molecular-characterization-with-an-emphasis-on-differential-diagnosis
#12
JOURNAL ARTICLE
Ming Zhao, Hualei Gan, Shan Zhong, Qiuyan Xia, Yanfeng Bai, Jiayun Xu, Xiaodong Teng, Jian Wang
Soft tissue neoplasms harboring fusions between EWSR1 or FUS with genes encoding CREB transcription factors family (ATF1, CREB1, and CREM) are an emerging heterogeneous group of mesenchymal tumors that differ significantly in morphology, immunophenotypes, and behavior. Recently, EWSR1/FUS::CREB fusions have been recognized to define a group of aggressive neoplasms of epithelioid morphology with multiple growth patterns and a striking predilection for mesothelial-lined cavities. These neoplasms presenting as a primary neoplasm of intra-abdominal visceral organs is rare, which could elicit a wide range of differential diagnoses due to their diverse morphologies and immunohistochemical profiles...
March 7, 2024: Modern Pathology
https://read.qxmd.com/read/38434963/inducing-melanoma-cell-apoptosis-by-erp57-pdia3-antibody-in-the-presence-of-cpi-613-and-hydroxychloroquine
#13
JOURNAL ARTICLE
Naohisa Ichiki, Chiemi Saigo, Yuki Hanamatsu, Hiroaki Iwata, Tamotsu Takeuchi
The combination of the cancer mitochondrial metabolic inhibitor CPI-613 and hydroxychloroquine has tumor-suppressive effects on clear cell sarcoma, which shares pathobiological properties with melanoma. Therefore, we intended to examine the effects of a combination of CPI-613 and hydroxychloroquine on the growth of melanoma cells in the present study. However, cell death was not induced in melanoma cells. Therefore, a monoclonal antibody, ICT, that induced apoptosis in melanoma cells in combination with CPI-613 and hydroxychloroquine was developed...
2024: Journal of Cancer
https://read.qxmd.com/read/38434682/a-case-report-synovial-sarcoma-of-the-mediastinum-in-an-18-year-old-teenager
#14
Yan Liu, Manman Cui, Xiuzhi Zhou, Duchang Zhai, Mingyu Qin, Guohua Fan, Wu Cai
Synovial sarcomas (SSs) are a rare group of malignant tumors originating from pluripotential mesenchymal cells, which commonly occur as the primary tumor in the soft tissues near the articular surface, tendons, and articular synovium. Herein, we report a rare case of mediastinal SS in an 18-year-old teenager who initially presented with cough as the primary symptom. In this case, plain chest CT and contrast-enhanced CT clearly revealed the lesion presenting as a round-like and uneven density mass in the mediastinum with heterogeneous enhancement, which compressed the trachea and invaded the adjacent vessels...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38433050/-detection-of-mdm2-gene-amplification-by-fluorescence-in-situ-hybridization-and-its-diagnostic-value-in-low-grade-osteosarcoma
#15
JOURNAL ARTICLE
L Li, M Zhang, R F Dong, Y B Su, Y Ding
Objective: To investigate the diagnostic value of detecting MDM2 gene amplification by fluorescence in situ hybridization (FISH) in low-grade osteosarcoma (LGOS). Methods: Thirty cases of parosteal osteosarcoma (POS) and 14 cases of low-grade central osteosarcoma (LGCOS) from April 2009 to August 2022 at Beijing Jishuitan Hospital, Capital Medical University were analyzed for the presence of MDM2 gene amplification by FISH. Fifty-eight additional cases were used as negative controls (including 28 cases of fibrous dysplasia, 5 cases of giant cell tumor, 4 cases of conventional osteosarcoma, 2 cases each of periosteal osteosarcoma, reparative changes after fracture, pleomorphic undifferentiated sarcoma, low grade myofibroblastic sarcoma, fibrous dysplasia with malignant transformation, one case each of leiomyosarcoma, sclerosing epithelioid fibrosarcoma, malignant peripheral nerve sheath tumor, desmoplastic fibroma of bone, solitary fibrous tumor, aneurysmal bone cyst, clear cell chondrosarcoma, osteofibrous dysplasia, and 3 cases of unclassified spindle cell tumor)...
March 8, 2024: Zhonghua Bing Li Xue za Zhi Chinese Journal of Pathology
https://read.qxmd.com/read/38396958/cytokine-signaling-in-pediatric-kidney-tumor-cell-lines-wt-cls1-wt-3ab-and-g-401
#16
JOURNAL ARTICLE
Elizaveta Fasler-Kan, Milan Milošević, Sabrina Ruggiero, Nijas Aliu, Dietmar Cholewa, Frank-Martin Häcker, Gabriela Dekany, Andreas Bartenstein, Steffen M Berger
Renal tumors comprise ~7% of all malignant pediatric tumors. Approximately 90% of pediatric kidney tumors comprise Wilms tumors, and the remaining 10% include clear cell sarcoma of the kidney, malignant rhabdoid tumor of the kidney, renal cell carcinoma and other rare renal tumors. Over the last 30 years, the role of cytokines and their receptors has been considerably investigated in both cancer progression and anti-cancer therapy. However, more effective immunotherapies require the cytokine profiling of each tumor type and comprehensive understanding of tumor biology...
February 14, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38396300/treatment-and-outcomes-of-clear-cell-sarcoma-of-the-kidney-a-report-from-the-children-s-oncology-group-studies-aren0321-and-aren03b2
#17
JOURNAL ARTICLE
Daniel J Benedetti, Lindsay A Renfro, Ian Tfirn, Najat C Daw, John A Kalapurakal, Peter F Ehrlich, Geetika Khanna, Elizabeth Perlman, Anne Warwick, Kenneth W Gow, Arnold C Paulino, Nita L Seibel, Paul Grundy, Conrad V Fernandez, James I Geller, Elizabeth A Mullen, Jeffrey S Dome
BACKGROUND: On the fifth National Wilms Tumor Study, treatment for clear cell sarcoma of the kidney (CCSK) included combined vincristine, doxorubicin, cyclophosphamide, and etoposide (regimen I) plus radiation therapy (RT), yielding 5-year event-free survival (EFS) rates of 100%, 88%, 73%, and 29% for patients who had with stage I, II, III, and IV disease, respectively. In the Children's Oncology Group study AREN0321 of risk-adapted therapy, RT was omitted for stage I disease if lymph nodes were sampled, and carboplatin was added for stage IV disease (regimen UH-1)...
February 23, 2024: Cancer
https://read.qxmd.com/read/38393424/evaluation-of-trim63-rna-in-situ-hybridization-rna-ish-as-a-potential-biomarker-for-alveolar-soft-part-sarcoma-asps
#18
JOURNAL ARTICLE
Alexander S Taylor, Rahul Mannan, Liron Pantanowitz, Arul M Chinnaiyan, Saravana M Dhanasekaran, Steven Hrycaj, Xuhong Cao, May P Chan, David Lucas, Xiao-Ming Wang, Rohit Mehra
Alveolar soft-part sarcoma (ASPS) is a rare soft tissue tumor with a broad morphologic differential diagnosis. While histology and immunohistochemistry can be suggestive, diagnosis often requires exclusion of other entities followed by confirmatory molecular analysis for its characteristic ASPSCR1-TFE3 fusion. Current stain-based biomarkers (such as immunohistochemistry for cathepsin K and TFE3) show relatively high sensitivity but may lack specificity, often showing staining in multiple other entities under diagnostic consideration...
February 23, 2024: Medical Oncology
https://read.qxmd.com/read/38391320/angiosarcoma-of-the-head-and-neck-a-clinicopathologic-study-with-special-emphasis-on-diagnostic-pitfalls
#19
JOURNAL ARTICLE
Jayapriya Gangadharan, Anitha Mathews, Sindhu N Prasanna Kumary, Thara Somanathan, K Jayasree, Geetha Narayanan
BACKGROUND AND AIMS: Angiosarcoma (AS) is a rare malignant vascular tumor that phenotypically and functionally recapitulate normal endothelium. They constitute approximately 2-4% of soft tissue sarcomas. We present 36 cases of head and neck AS diagnosed for 11 years at a tertiary care hospital in South India to analyze the clinical, pathological, and immunophenotypic profiles with special emphasis on their differential diagnoses and diagnostic pitfalls. MATERIALS AND METHODS: Head and neck AS diagnosed from January 2006 to December 2017 were included...
February 14, 2024: Indian Journal of Pathology & Microbiology
https://read.qxmd.com/read/38377388/18f-fdg-pet-ct-in-a-case-of-clear-cell-sarcoma-of-the-kidney
#20
JOURNAL ARTICLE
Hongfu Jin, Yafu Yin, Hui Wang, Weiwei Cheng
18F-FDG PET/CT was performed in a 1-year-old girl who had a heterogeneous mass in the right abdominal cavity revealed by abdominal ultrasound. A heterogeneous mass with internal necrosis, cystic changes, and hemorrhage in the right kidney, accompanied by a slight increase of FDG uptake, was observed in FDG PET/CT. Malignant renal tumor was considered, and Wilms tumor was preferentially suspected. However, the mass was demonstrated as clear cell sarcoma of the kidney by histopathological examination.
February 8, 2024: Clinical Nuclear Medicine
keyword
keyword
81661
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.